[
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_1",
            "program_id": "PROGRAM_1",
            "submitter_donor_id": "DONOR_1",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_1",
            "treatment_type": [
                "Endoscopic therapy",
                "Photodynamic therapy"
            ],
            "is_primary_treatment": "Yes",
            "treatment_start_date": "2021-02",
            "treatment_end_date": "2022-09",
            "treatment_setting": "Neoadjuvant",
            "treatment_intent": "Palliative",
            "days_per_cycle": 1,
            "number_of_cycles": 3,
            "response_to_treatment_criteria_method": "Cheson CLL 2012 Oncology Response Criteria",
            "response_to_treatment": "Stable disease"
        }
    },
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_2",
            "program_id": "PROGRAM_1",
            "submitter_donor_id": "DONOR_1",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_1",
            "treatment_type": [
                "Radiation therapy",
                "Bone marrow transplant",
                "Surgery"
            ],
            "is_primary_treatment": "Yes",
            "treatment_start_date": "2021-09",
            "treatment_end_date": "2022-05",
            "treatment_setting": "Not applicable",
            "treatment_intent": "Curative",
            "days_per_cycle": 2,
            "number_of_cycles": 3,
            "response_to_treatment_criteria_method": "Response Assessment in Neuro-Oncology (RANO)",
            "response_to_treatment": "Minor response"
        }
    },
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_3",
            "program_id": "PROGRAM_1",
            "submitter_donor_id": "DONOR_1",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_1",
            "treatment_type": [
                "No treatment",
                "Hormonal therapy",
                "Other targeting molecular therapy"
            ],
            "is_primary_treatment": "Yes",
            "treatment_start_date": "2021-03",
            "treatment_end_date": "2022-10",
            "treatment_setting": "Adjuvant",
            "treatment_intent": "Palliative",
            "days_per_cycle": 1,
            "number_of_cycles": 4,
            "response_to_treatment_criteria_method": "Cheson CLL 2012 Oncology Response Criteria",
            "response_to_treatment": "Immune partial response (iPR)"
        }
    },
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_4",
            "program_id": "PROGRAM_1",
            "submitter_donor_id": "DONOR_1",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_2",
            "treatment_type": [
                "Chemotherapy",
                "Ablation"
            ],
            "is_primary_treatment": "Yes",
            "treatment_start_date": "2021-06",
            "treatment_end_date": "2022-05",
            "treatment_setting": "Not applicable",
            "treatment_intent": "Curative",
            "days_per_cycle": 7,
            "number_of_cycles": 3,
            "response_to_treatment_criteria_method": "iRECIST",
            "response_to_treatment": "Progressive disease"
        }
    },
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_5",
            "program_id": "PROGRAM_1",
            "submitter_donor_id": "DONOR_1",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_2",
            "treatment_type": [
                "Immunotherapy"
            ],
            "is_primary_treatment": "No",
            "treatment_start_date": "2021-10",
            "treatment_end_date": "2022-04",
            "treatment_setting": "Adjuvant",
            "treatment_intent": "Curative",
            "days_per_cycle": 2,
            "number_of_cycles": 5,
            "response_to_treatment_criteria_method": "iRECIST",
            "response_to_treatment": "Complete remission with incomplete hematologic recovery (CRi)"
        }
    },
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_6",
            "program_id": "PROGRAM_1",
            "submitter_donor_id": "DONOR_1",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_2",
            "treatment_type": [
                "Radiation therapy",
                "Ablation"
            ],
            "is_primary_treatment": "Unknown",
            "treatment_start_date": "2021-03",
            "treatment_end_date": "2022-09",
            "treatment_setting": "Adjuvant",
            "treatment_intent": "Curative",
            "days_per_cycle": 6,
            "number_of_cycles": 3,
            "response_to_treatment_criteria_method": "Physician Assessed Response Criteria",
            "response_to_treatment": "Immune stable disease (iSD)"
        }
    },
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_7",
            "program_id": "PROGRAM_1",
            "submitter_donor_id": "DONOR_1",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_3",
            "treatment_type": [
                "Chemotherapy",
                "Ablation",
                "Bone marrow transplant"
            ],
            "is_primary_treatment": "No",
            "treatment_start_date": "2021-06",
            "treatment_end_date": "2022-03",
            "treatment_setting": "Not applicable",
            "treatment_intent": "Curative",
            "days_per_cycle": 3,
            "number_of_cycles": 3,
            "response_to_treatment_criteria_method": "Cheson CLL 2012 Oncology Response Criteria",
            "response_to_treatment": "Molecular relapse (after CR MRD-)"
        }
    },
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_8",
            "program_id": "PROGRAM_1",
            "submitter_donor_id": "DONOR_1",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_3",
            "treatment_type": [
                "Bone marrow transplant",
                "Ablation"
            ],
            "is_primary_treatment": "Yes",
            "treatment_start_date": "2021-03",
            "treatment_end_date": "2022-10",
            "treatment_setting": "Not applicable",
            "treatment_intent": "Palliative",
            "days_per_cycle": 1,
            "number_of_cycles": 5,
            "response_to_treatment_criteria_method": "AML Response Criteria",
            "response_to_treatment": "Minor response"
        }
    },
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_9",
            "program_id": "PROGRAM_1",
            "submitter_donor_id": "DONOR_2",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_4",
            "treatment_type": [
                "Radiation therapy",
                "Photodynamic therapy",
                "Endoscopic therapy"
            ],
            "is_primary_treatment": "Unknown",
            "treatment_start_date": "2021-07",
            "treatment_end_date": "2022-07",
            "treatment_setting": "Adjuvant",
            "treatment_intent": "Curative",
            "days_per_cycle": 7,
            "number_of_cycles": 4,
            "response_to_treatment_criteria_method": "iRECIST",
            "response_to_treatment": "Complete remission without measurable residual disease (CR MRD-)"
        }
    },
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_10",
            "program_id": "PROGRAM_1",
            "submitter_donor_id": "DONOR_2",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_4",
            "treatment_type": [
                "No treatment"
            ],
            "is_primary_treatment": "No",
            "treatment_start_date": "2021-12",
            "treatment_end_date": "2022-08",
            "treatment_setting": "Adjuvant",
            "treatment_intent": "Curative",
            "days_per_cycle": 3,
            "number_of_cycles": 3,
            "response_to_treatment_criteria_method": "iRECIST",
            "response_to_treatment": "Minor response"
        }
    },
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_11",
            "program_id": "PROGRAM_1",
            "submitter_donor_id": "DONOR_2",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_5",
            "treatment_type": [
                "Other targeting molecular therapy",
                "Photodynamic therapy",
                "No treatment"
            ],
            "is_primary_treatment": "No",
            "treatment_start_date": "2021-12",
            "treatment_end_date": "2022-07",
            "treatment_setting": "Not applicable",
            "treatment_intent": "Curative",
            "days_per_cycle": 4,
            "number_of_cycles": 3,
            "response_to_treatment_criteria_method": "iRECIST",
            "response_to_treatment": "Immune partial response (iPR)"
        }
    },
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_12",
            "program_id": "PROGRAM_1",
            "submitter_donor_id": "DONOR_2",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_6",
            "treatment_type": [
                "Bone marrow transplant",
                "Stem cell transplant"
            ],
            "is_primary_treatment": "No",
            "treatment_start_date": "2021-10",
            "treatment_end_date": "2022-10",
            "treatment_setting": "Advanced/Metastatic",
            "treatment_intent": "Palliative",
            "days_per_cycle": 6,
            "number_of_cycles": 4,
            "response_to_treatment_criteria_method": "Physician Assessed Response Criteria",
            "response_to_treatment": "Complete remission without measurable residual disease (CR MRD-)"
        }
    },
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_13",
            "program_id": "PROGRAM_1",
            "submitter_donor_id": "DONOR_3",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_7",
            "treatment_type": [
                "Photodynamic therapy"
            ],
            "is_primary_treatment": "Yes",
            "treatment_start_date": "2021-09",
            "treatment_end_date": "2022-05",
            "treatment_setting": "Advanced/Metastatic",
            "treatment_intent": "Curative",
            "days_per_cycle": 3,
            "number_of_cycles": 5,
            "response_to_treatment_criteria_method": "RECIST 1.1",
            "response_to_treatment": "Immune stable disease (iSD)"
        }
    },
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_14",
            "program_id": "PROGRAM_1",
            "submitter_donor_id": "DONOR_3",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_8",
            "treatment_type": [
                "Endoscopic therapy",
                "Bone marrow transplant"
            ],
            "is_primary_treatment": "Yes",
            "treatment_start_date": "2021-03",
            "treatment_end_date": "2022-01",
            "treatment_setting": "Advanced/Metastatic",
            "treatment_intent": "Curative",
            "days_per_cycle": 4,
            "number_of_cycles": 4,
            "response_to_treatment_criteria_method": "Cheson CLL 2012 Oncology Response Criteria",
            "response_to_treatment": "No evidence of disease (NED)"
        }
    },
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_15",
            "program_id": "PROGRAM_1",
            "submitter_donor_id": "DONOR_4",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_9",
            "treatment_type": [
                "Radiation therapy",
                "No treatment"
            ],
            "is_primary_treatment": "Yes",
            "treatment_start_date": "2021-06",
            "treatment_end_date": "2022-03",
            "treatment_setting": "Not applicable",
            "treatment_intent": "Curative",
            "days_per_cycle": 3,
            "number_of_cycles": 5,
            "response_to_treatment_criteria_method": "AML Response Criteria",
            "response_to_treatment": "Physician assessed stable disease"
        }
    },
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_16",
            "program_id": "PROGRAM_1",
            "submitter_donor_id": "DONOR_4",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_10",
            "treatment_type": [
                "Bone marrow transplant",
                "Chemotherapy"
            ],
            "is_primary_treatment": "No",
            "treatment_start_date": "2021-06",
            "treatment_end_date": "2022-10",
            "treatment_setting": "Adjuvant",
            "treatment_intent": "Curative",
            "days_per_cycle": 7,
            "number_of_cycles": 4,
            "response_to_treatment_criteria_method": "Physician Assessed Response Criteria",
            "response_to_treatment": "Complete remission with incomplete hematologic recovery (CRi)"
        }
    },
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_17",
            "program_id": "PROGRAM_1",
            "submitter_donor_id": "DONOR_5",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_11",
            "treatment_type": [
                "Other targeting molecular therapy"
            ],
            "is_primary_treatment": "Yes",
            "treatment_start_date": "2021-09",
            "treatment_end_date": "2022-06",
            "treatment_setting": "Not applicable",
            "treatment_intent": "Curative",
            "days_per_cycle": 3,
            "number_of_cycles": 4,
            "response_to_treatment_criteria_method": "Cheson CLL 2012 Oncology Response Criteria",
            "response_to_treatment": "Immune stable disease (iSD)"
        }
    },
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_18",
            "program_id": "PROGRAM_1",
            "submitter_donor_id": "DONOR_6",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_12",
            "treatment_type": [
                "Bone marrow transplant"
            ],
            "is_primary_treatment": "No",
            "treatment_start_date": "2021-02",
            "treatment_end_date": "2022-06",
            "treatment_setting": "Adjuvant",
            "treatment_intent": "Palliative",
            "days_per_cycle": 1,
            "number_of_cycles": 4,
            "response_to_treatment_criteria_method": "Cheson CLL 2012 Oncology Response Criteria",
            "response_to_treatment": "Partial response"
        }
    },
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_19",
            "program_id": "PROGRAM_2",
            "submitter_donor_id": "DONOR_7",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_13",
            "treatment_type": [
                "Bone marrow transplant"
            ],
            "is_primary_treatment": "No",
            "treatment_start_date": "2021-04",
            "treatment_end_date": "2022-01",
            "treatment_setting": "Advanced/Metastatic",
            "treatment_intent": "Curative",
            "days_per_cycle": 1,
            "number_of_cycles": 4,
            "response_to_treatment_criteria_method": "Response Assessment in Neuro-Oncology (RANO)",
            "response_to_treatment": "Partial response"
        }
    },
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_20",
            "program_id": "PROGRAM_2",
            "submitter_donor_id": "DONOR_8",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_14",
            "treatment_type": [
                "Chemotherapy",
                "Photodynamic therapy",
                "Endoscopic therapy"
            ],
            "is_primary_treatment": "Unknown",
            "treatment_start_date": "2021-10",
            "treatment_end_date": "2022-04",
            "treatment_setting": "Adjuvant",
            "treatment_intent": "Palliative",
            "days_per_cycle": 4,
            "number_of_cycles": 5,
            "response_to_treatment_criteria_method": "iRECIST",
            "response_to_treatment": "Molecular relapse (after CR MRD-)"
        }
    },
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_21",
            "program_id": "PROGRAM_2",
            "submitter_donor_id": "DONOR_9",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_15",
            "treatment_type": [
                "Other targeting molecular therapy"
            ],
            "is_primary_treatment": "No",
            "treatment_start_date": "2021-11",
            "treatment_end_date": "2022-08",
            "treatment_setting": "Neoadjuvant",
            "treatment_intent": "Curative",
            "days_per_cycle": 5,
            "number_of_cycles": 3,
            "response_to_treatment_criteria_method": "Response Assessment in Neuro-Oncology (RANO)",
            "response_to_treatment": "Molecular relapse (after CR MRD-)"
        }
    },
    {
        "model": "mohpackets.treatment",
        "fields": {
            "submitter_treatment_id": "TREATMENT_22",
            "program_id": "PROGRAM_2",
            "submitter_donor_id": "DONOR_10",
            "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_16",
            "treatment_type": [
                "Other targeting molecular therapy",
                "Immunotherapy",
                "No treatment"
            ],
            "is_primary_treatment": "No",
            "treatment_start_date": "2021-06",
            "treatment_end_date": "2022-07",
            "treatment_setting": "Advanced/Metastatic",
            "treatment_intent": "Curative",
            "days_per_cycle": 4,
            "number_of_cycles": 3,
            "response_to_treatment_criteria_method": "Response Assessment in Neuro-Oncology (RANO)",
            "response_to_treatment": "No evidence of disease (NED)"
        }
    }
]